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ABSTRACT 
Objective. For government officials and health providers, elderly population - aged 
65 and over, especially neurosurgical patient, represent a larger concern, an 
increasing problem not only for socio-economic reasons related to the medical act, 
but also for additional care requirements which should be done by the family and 
society, including rehabilitation facilities, occupational & physical therapy, speech 
therapists, visiting nurses, to insure an effective recuperation after hospital 
discharge. A retrospective study with 325 "elderly" patients cohort, aged 65 and over, 
admitted in the Neurosurgery Department undergoing common neurosurgical 
procedures, in the last five years offer an evaluation for neurosurgical procedures, 
outcomes, comorbidities, anaesthetic and analgesic requirements, outcome.  
Material and method. This study was performed on patients aged 65 years or older, 
with neurosurgical diseases, admitted to the Neurosurgery or the Intensive Care Unit 
of our hospital, between 2014-2019. An analysis was made on variables such as age, 
pathology, comorbidities, length of hospital stay especially in the ICU unit, type of 
cranio-cerebral or spinal procedures performed, anaesthesia protocols, 
complications, performance status, re-admissions and mortality. 
Results. Patients age were divided into three categories: between 65-70 years old 
there were 152 patients (46,76%), between 70-85 years old 93 patients (28.61%) and 
over 85 years old 80 patients (24,61%). 173 patients were females (53,23%), 152 were 
males (46.76 %). The admission Glasgow Coma Scale (GCS) score to those over 85 
years old was between 3-12 in 29 cases (8.02%) with early death in 13 patients. 
Several comorbidities were noticed in 294 patients (90.15%): cardiac, pulmonary, 
hematologic especially coumarinic overdose, hepatic and renal failures, psychiatric 
illnesses, concomitant systemic disease or immunosuppressed patients by 
decompensated diabetes, primitive cancers affecting various organs, infectious 
diseases, also severe osteoporosis, chronic ethylic intoxication, limiting surgical 
attitude, also obtaining the informed consent for surgery. There were 154 (47,38%) 
patients with cerebral pathology and 171 (52,61%) patients with spinal pathology. 
Most common surgical procedures performed were: craniotomies for tumours and 
hematoma removal, minimal invasive procedures for spine, endovascular and 
vertebroplasty. The median length of stay for emergency patients was significantly 
longer than that of elective patients (13 vs. 8 days). For 215 (66.15%) patients general 
anaesthesia was performed, local anaesthesia in 97 (29.84%) patients, 13 patients 
(4%) were not operated. Good quality of life results appreciated by patients and 
relatives were recorded in 236 cases (72.61%) in the first and second category; less 
better results to those over 85 years old; same symptoms especially pain 63 patients 
(19.38%), complications to 47 patients (14,46%) especially cardiac, renal and  
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respiratory failures, also motor deficits, seizures, CSF fistula, 
mortality in 26 cases (8%), re-admissions in 45 cases (13.84%) 
less than 1 month after discharge.  
Conclusions. Old prejudices that old age is a contraindication 
for surgery have to be removed. Clinical and surgical decisions 
for neurosurgical procedures in the elderly are decisive for 
limiting reported morbidity and mortality rates. For life quality, 
realistic family and society expectations, several aspects should 
be considered for safe and effective results: careful patient 
selection on patient status, comorbidities and physiological 
reserve; neurosurgical pathology, urgency of the surgical 
procedure, the strategy of neurosurgical management based 
on advances in imaging and interventional radiology, minimal 
invasive neurosurgical procedures with significant 
preoperative and postoperative care. Good results could be 
obtained even in elderly people for chronic subdural 
hematoma, simple brain or spinal tumour, good grade 
aneurysm, trigeminal pain, vertebroplasty in spinal vertebral 
fractures, etc. 
 
INTRODUCTION 
Aging means concomitant a physiological process 
but also structural degeneration, a graded loss of 
functional capacity of all organs and tissues (1)(2). 
The number of elderly patients is increasing 
worldwide, generating a larger concern (3-7), an 
increasing problem regarding socio-economic 
reasons related to the medical act, morbidity and 
additional care requirements, perioperative adverse 
events (8-10). It is estimated that between 2000 and 
2050, the proportion of the world's population over 
60 years will double, and the number of people aged 
80 and older will quadruple (7)(11). For neurosurgical 
patient, beyond the age of 65 years, both chronic or 
in emergency, all measures should be institute to 
maintain quality of life, to avoid perioperative 
mortality and morbidity (10). In Romania the share of 
people over 65 years of age, was 18% of the total 
population on January 1, 2018, respectively 
3,559,957 persons out of 19,523,621. According to 
the NIS data, among the elderly, the men numbered 
1,433,412 persons (15% of the total number of men 
in Romania of 9,543,228 persons) and the women 
2,117,495 (21% of the total number of women 
residing in Romania of 9,980,393 persons)(12).  
 
MATERIAL AND METHOD 
This retrospective study was performed on 325 
patients aged 65 years or older, with neurosurgical 
diseases, admitted to the Neurosurgery or the 
Intensive Care Unit of our hospital, between 2014-
2019. An analysis was made on variables such as: 
age, pathology, the admission Glasgow Coma Scale 
(GCS) score, both chronic or in emergency, 
comorbidities - using Charlson Comorbidity Index 
(13)(14), length of hospital stay especially in the ICU 
unit, type of cranio-cerebral or spinal procedures 
performed, anaesthesia protocols, complications, 
performance status, re-admissions morbidity and 
mortality. 45.8% of patients had neurosurgical 
cranial pathology and 54,2% had neurosurgical 
spinal diseases. Patients age were divided into three 
categories: between 65-70 years old there were 152 
patients (46,76%), between 70-85 years old 93 
patients (28.61%) and over 85 years old 80 patients 
(24,61%). 173 patients were females (53,23%), 152 
were males (46.76 %). The admission Glasgow Coma 
Scale (GCS) score was between 3-15, worse: between 
3-5 especially to those over 85 years old in 29 cases 
(8.02%) with early death in 13 patients. A CGS score 
between 7-14 was recorded to 89 patients (27,38%): 
12 cases (3.69%) in the first category, 42 cases 
(12.95%) cases in the second and 35 cases (10.76%) 
in the third. Several combined comorbidities were 
encountered in 294 patients (90.15%), limiting 
surgical attitude, also obtaining the informed 
consent for surgery: cardiac insufficiency, several 
cardiac diseases with damage to the ejection fraction 
(myocardial infarction, arrhythmias, valvular stenosis 
or insufficiency, untreated hypertension); chronic 
pulmonary disease, bronchial asthma; previous 
strokes with hemiplegia; severe haematological 
diseases (lymphoma, leukemia, myeloma, 
coagulation disorders with thrombocytopenia or 
coumarinic overdose); hepatopathy (cirrhosis, portal 
hypertension with variceal bleeding history, chronic 
hepatitis); kidney failure - patients submitted in the 
dialysis program; peptic ulcer disease; connective 
tissue disease; peripheral vascular disease 
(intermittent claudication, chronic arterial 
insufficiency with by-pass, untreated thoracic or 
abdominal aneurysm), psychiatric illnesses 
(dementia); concomitant systemic disease or 
immunosuppressed patients by diabetes, primitive 
and metastatic cancers affecting various organs, 
chemotherapies, transplant patients, infectious 
diseases even AIDS; severe osteoporosis, chronic 
ethylic intoxication, drug allergies.  
Neurosurgical pathologies varied alone or 
concurrently: 154 (47,38%) patients with cerebral 
pathology and 171 (52,61%) patients with spinal 
pathology: cranio-cerebral and spinal trauma 
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(hematomas: epidural, subdural, intracerebral, 
posttraumatic subarachnoid haemorrhage, cerebral 
and spinal contusions, DAI, cerebral lacerations, CSF 
fistula, Schneider syndrome, hematomyelia); 
cerebral tumours: extraaxial meningioma, 
metastasis, gliomas especially glioblastoma, 
schwanomas, pituitary and spinal tumours: 
extradural, intradural, intramedullary, frequent 
metastasis in lung, breast, prostate cancer; cerebral 
aneurysm, carotid-cavernous fistula, MAV, spinal 
degenerative myeloradiculopathy, mielopathy with 
cervical and lumbar canal stenosis, spinal instability 
with osteoporotic vertebral changes, vertebral 
fractures; Arnold neuralgia, trigeminal, atypical facial 
pain, spinal neuropathic pain; tremor (Parkinson's 
syndroms & disease, dystonic movements), 
blepharospasm even Meige syndrome, spasmodic 
torticollis. All patients were carefully neurologic, 
biologic, neuro-imagistic, multidisciplinary 
evaluated; neurosurgical surgical indication, 
anaesthesia protocol, informed consent to be used 
to each patient were supported with accuracy. 
Several procedures have been performed: 
craniotomies for tumours and hematoma removal, 
minimal invasive procedures for spine, 
endovascular, vertebroplasty, nerve block, neuro-
vascular decompression or Gamma-Knife for pain 
procedures have been performed. 
 
RESULTS 
The median length of stay for emergency patients 
was significantly longer than that of elective patients 
ranged between 13 vs.8 days, and in the ICU unit vary 
from 1 to 63 days. 
For 215 (66.15%) patients general anaesthesia 
was performed, local anaesthesia in 97 (29.84%) 
patients, 13 patients (4%) were not operated. Good 
quality of life results appreciated by patients and 
relatives were recorded in 236 cases (72.61%) in the 
first and second category; less better results to those 
over 85 years old; same symptoms especially pain 63 
patients (19.38%), complications to 47 patients 
(14,46%) especially cardiac, renal and respiratory 
failures, also motor deficits, seizures, CSF fistula, 
mortality in 26 cases (8%), re-admissions in 45 cases 
(13.84%) less than 1 month after discharge. For old 
patients physical therapists may improve strength 
and balance, safely walk ability, climb stairs before 
being released from the hospital. Occupational 
therapists may help such patients to be able to do 
personal hygiene using the bathroom, to get 
dressed; speech language pathologists could help 
patients with speech, language or thinking. 
 
DISCUSSION 
The elderly patient - defined as an individual 65 years 
of age and over, still represent all around world in 
general, a fragile population, a great concern, with 
higher costs of health care, a difficult issue for the 
health systems struggling with limited resources (3-
7)(9)(10). For each aging person there are a personal 
rate of degeneration of CNS as like as the whole 
body, in anatomy, in mental and physical activity, 
also in higher costs of living, lifestyle change, 
loneliness, possible dependence of specific 
medication for medical associated illnesses - such as 
diabetes and cardiovascular disease (3)(6). It's also a 
reality that the elderly population represent the 
fastest growing segment of the world's population; 
the world's population over 60 years will double 
between 2000 and 2050 and the number of people 
aged 80 and older will quadruple (7). 47,8 million the 
number of people age 65 and older in the United 
States on July 1,2015; this group accounted for 14,9 
per cent of the total population (15). 98,2 million - the 
projected population of people age 65 and older in 
2060; of this number 9,7 million will be age 85 or 
older (16). Such growing proportion affect also the 
neurosurgical admissions both in emergency 
surgeries or classical presentations for every group 
of persons on age “young-old” - 65-74, “middle-old” -
75-84 and “old-old” > 85 (17). There are several 
changes involved in different degree with age, with 
neurosurgical interest too (1)(2)(18-23): 
 
-cerebral atrophy affecting especially the frontal and 
temporal lobes, decline in brain weight, increase in 
ventricular size, thickening of meninges, decrease in 
width of gyri, deep sulci, cortical neurons, myelinated 
axons, the number of synapses per neuron, loss of 
Nissl substance, nuclear atrophy; intracellular 
deposits, granulation or fragmentation of 
mitochondria. These aspects are generating 
tolerance in front of any expansive process, clinical 
onset delay in case of tumours, intracranial 
hematoma, facilitates surgical approach, allows 
intracranial expansive processes removal. 
 
-cerebral fragility with decreased cerebral compliance 
that induces the brain's difficulty to resume its 
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anterior position, able to generate hematoma 
recurrence, hydrocephalus, etc. 
 
-decreased cerebral blood flow, loss of vascular 
autoregulation and responsiveness to neuronal 
demand, hypercapnia, heterogeneous regional 
variations with decreased cellular oxygen, glucose 
and oxidative metabolism, altered sodium, 
potassium and calcium homeostasis with reduced 
axoplasmatic transport, calcium mediated and 
synaptic neurotransmitter release. There are also 
general decrease in excitability, peripheral nerve 
conduction velocity, altered reflex responses and 
increased latency of evoked potential, a 
disorganization of highly coordinated activities, with 
autonomic and homeostatic changes: reduced 
temperature regulation, orthostatic hypotension, 
chronic constipation, slowed hear rate, decreased 
blood pressure.  
 
-leukoaraiosis (gr."leuko-" = white, meaning white 
matter and the adjective «araios" ="thin."- Hachinski 
V. 1987) are typically generated by: lacunar 
stroke/transient ischemic attack (TIA), dementia of 
both vascular and non-vascular etiologies 
(hypertension, degenerative, in Alzheimer's disease), 
sporadic cerebral amyloid angiopathy, diabetes; the 
precise pathogenic mechanisms remain unclear. 
Recent genetic results strongly supported that 
leukoaraiosis is associated with immune response 
and neuroinflammation (23). Pathologically, 
leukoaraiosis is characterized by white matter gliosis, 
axonal and myelin loss, increased perivascular 
spaces, patchy demyelination, hyaline thickening 
and arteriosclerosis of small vessels that can evolve 
to lipohyalinosis, fibrinoid necrosis, and denudation 
of ependyma. Main clinical manifestations are 
cognitive and executive troubles (memory loss 
especially short-term memory, visual and hearing 
loss, declining endurance, verbal intelligence, 
processing speech dysfunction in learning and 
language skills, depression), ankle jerks decreased or 
absent, increased primitive reflexes (glabella, palmo-
mental), slowed forward flexed, altered gait, tremor 
with loss of fine motor coordination bladder 
instability. There are hypo-dense areas to cerebral 
CT scan, diffuse, heterogeneous, imprecisely 
delimited, primarily interesting the centre of the 
white substance or the immediate subcortical areas. 
The MRI examination in weighted T1 sequences 
shows hypointense areas and the weighted T2 
sequences show hyperintense areas; sometimes 
without correlation as number, localization. MRI 
findings are commonly seen to elderly people with 
prevalence ranging from 50% to 100%. Leukoaraiosis 
may explain poor clinical outcomes and increases 
the risk of disability, dementia, depression, stroke, 
and the overall morbidity and mortality.  
 
-amyloid angiopathy > 70 years: explains the 
difficulties of hemostasis, haemorrhagic 
recurrences, preanesthetic assessment, informed 
consent, perioperative evaluation, risk issues 
especially for those people identified with ASA 
physical status of III or IV. and care are magnified in 
older patient, anaesthetic management, efficient 
surgical skills procedures - especially functional 
neurosurgery, radiosurgery, planned postoperative 
management may contribute to successful 
outcomes also to ameliorate quality of life related to 
neurosurgical diseases, also to a specific 
neurosurgical pathology, especially pain 
(3)(5)(7)(8)(10)(11)(24-29). There are medical factors 
affecting anaesthesia: multiple medical 
comorbidities including sepsis, metabolic 
disturbances severe obesity or poor nutritional 
status, alcohol and/or drug abuse, history of cardiac 
failure or myocardial infarction ≤ 1 year with low 
ejection fraction (EF) on echocardiography, severe 
uncontrolled hypertension, severe respiratory 
dysfunction, hepato-renal failures, neurovascular, 
psychiatric disease, history of CVA or TIA, peripheral 
vascular disease, immuno-compromised patients by 
diabetes, tuberculosis, etc; severe coagulopathy 
status with trombocytemia, haemophilia, 
antiplatelet agents even help syndrome (to old 
patients even a normal coagulogram may coexist 
with difficult hemostasis), cognitive function at risk 
especially at advanced age > 70 years: cognitive 
impairment, acute confusional state, delirium. There 
are also surgical factors affecting anaesthesia in all 
such high-risk geriatric patients which should be 
discussed in detail for optimizing the outcome with 
the anaesthesiologist and cardiologist (28)(29): 
 
-surgical position: prone, sitting, Concorde position 
have always cardio-respiratory implications, Wilson 
Frame or similar with varying degrees of inclination, 
neck stabilization, spine traction, requirement of 
elective ventilation, head up to 10 degree and 
reverse Trendelenburg may avoid perioperative 
blindness by direct/indirect eye pressure, ischemic 
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optic neuropathy, central retinal artery occlusion 
(CRAO), cortical blindness. Also a severe spinal 
trauma or an important scoliosis, osteoporosis, 
osteomyelitis, severe obesity or undernourished 
people. 
 
-plan of surgical excision, anticipated duration (in 
general surgery should never exceed 6.5 h in older 
patient), anticipated blood loss, neurophysiologic 
monitoring, postoperative ventilation. The 
anaesthetic regimen has to be tailored according to 
the physiological reserve: local or general 
anaesthesia. For general anaesthesia there are 
several remarks: 
 
-before induction the invasive monitoring for arterial 
blood pressure - ABP and central venous pressure - 
CVP should be instituted under local anaesthesia. 
 
-induction should be performed with fentanyl, 
etomidate (etomidate requirement beyond the age 
of 80 years may decrease by 50%,), non depolarisant 
muscular blockade agents intravenously. Propofol 
produces an exaggerated fall in blood pressure 
especially to old patients, dehydrated, midazolam 
has increased duration and potency, neuromuscular 
blocking agents are unchanged oral intubation. 
 
-anaesthesia should be maintained with 50% oxygen, 
air, sevoflurane in minimum alveolar concentration - 
MAC of 0.5 (MAC requirement for volatiles also 
decreases in the elderly, though the onset may be 
delayed due to decreased cardiac output). 
Monitoring should be performed by pulse oximetry: 
SpO2, arterial blood pressure ABP avoiding acidosis, 
hyper or hypotension - 84 mm systolic minimum, Hct 
> 28%/, Hb > 9.4 with cardiac index (stroke volume) ↓ 
24%; blood loss > 45%, heart rate HR, 
electrocardiogram ECG, end-tidal carbon dioxide, 
hourly urine output, temperature. To maintain 
hemodynamics and to avoid cerebral perfusion 
pressure crash crystalloids and noradrenaline 
should be infused intraoperatively.  
 
-even in case with normal coagulation test, 
haemostasis could be laborious in the confined 
space of the cranial cavity or the spinal canal 
presenting as the surgical field; in case of bleeding 
diathesis (due to prescribed medications in the form 
of clopidogrel, warfarin, etc., alone or more often in 
combination) especially in emergency this is 
dangerous. For such situations there are several 
costly, time consuming, delaying procedures: red 
blood cell transfusion, donor platelet, frozen plasma, 
Novoseven, Pronative, Hemocompletan, 
recombinant factor VIIa, all of this are costly, time 
consuming, delay procedures. 
 
-postop. Slowly awakening, extubated and closely 
watched in neurosurgical intensive care unit to 
improve resource utilization, decreased in-hospital 
mortality (26). The effect of depth of anaesthesia on 
outcomes is still a grey area. Perioperative cardiac - 
maintaining volume status, pulmonary evaluation 
are reliable predictors of complications, (ex. 
unoptimized pulmonary diseases, increased closing 
volumes and decreased expiratory flow rates, 
tracheostomy, postoperative mechanical ventilation) 
predispose older patients to complications and 
death, also renal status avoiding nephrotoxic drugs, 
prevention of hyperglycemia or hypoglycemia, 
adequate prophylaxis for deep venous thrombosis - 
even with pneumatic compression devices, multiple 
medications for other co-morbidities. Mental status 
should be assessed preoperatively because 
dementia is a predictor of poor outcome 
perioperatively, increasing mortality by 50% (25). 
Nutritional deficiencies should be corrected because 
they play a role in wound healing and recovery - 
albumin levels of < 3.2 g/dl in hospitalized elderly 
patients increased perioperative mortality (28), also 
pain should be treated.  
 
Most common geriatric pathology are: 
-traumatic brain injuries, more common: subdural uni 
or bilateral hematoma - a common pathology 
(11)(30-35), mainly affecting elderly patients, " not a 
benign disease" (34) In patients over 80 years old 
chronic subdural hematoma incidence is reported 
127.1/100.000/year, with a mortality of less than 
10%, a history of head injury is not always admitted, 
several cases could be under anticoagulant 
treatment because of cardiac pathologies or ictus 
cerebri, arterial hypertension, diabetes mellitus with 
severe thrombocytopenia, high INR, even with a 
normal coagulogramm haemostasis may be difficult. 
The most common clinical presentation include 
hemiparesis, disphasia/ aphasia, disorientation, 
hemianopsia. Diagnosis is sustained on CT scan. 
Anaesthesia should be local or general, to correct a 
severe coagulopathy may be necessary: 
thrombocytes, Novoseven-factor VII, Pronativ, 
Hemocompletan in case of fibrinolysis. Several 
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surgical techniques could be used: craniotomy 
centred on the thickest portion of the clot (useful in 
clots that can't be evacuated through a simple trepan 
hole, allows brain to resume its anterior position, to 
evacuate a concomitant intracerebral hematoma, to 
monitor intracranial pressure in those with CGS <9 
Bullock et al, allows haemostasis), craniotomy, useful 
when intracranial pressure is maintained, requiring 
removal of the bone, trephination or two - several 
trepan holes in the thickest parts of the hematoma 
(for example, frontal and parietal that may be 
needed to be incorporated into a fronto-temporo-
parietal craniotomy in case of relapse, hematoma 
consistency, thick membranes), the subdural 
evacuating port system (SEPS): the minimally invasive 
technique, a safe method, effective in subacute and 
chronic subdural hematoma in elderly patients, easy 
to perform with local or general anaesthesia, it takes 
less than 10 minutes, without irrigation, aspiration, 
catheter (36). Postop complications are: recurrences, 
persistence of preop. brain position by decreased 
cerebral compliance, parenchymal haemorrhages in 
the same hemisphere or controlateral. Outcome are 
measured with Glasgow outcome scale (GOS) or 
Markwalder grading system (MGS) to evaluate 
improvement in neurological function in general a 
good GOS in 86.1% of patients older than 80 years 
(11), the discharge disposition to return to an 
independent life, to rehabilitation or nursing home. 
There are also cerebral contusions and lacerations, 
rare extradural hematoma with late shift effect of 
cerebral parenchima, veins ruptures and 
haemorrhagic events, dimished recovery capacity. 
 
-cerebral aneurysm and less frequent cerebral arterio-
venos malformation with subarahnoidian 
haemorrhage, ischemic & haemorrhagic strokes supra 
and infratentorial, associated with hydrocephalus and 
occlusive cerebrovascular disease 40% (3)(37).  
 
-epilepsy to older patients is are more frequent (the 
annual incidence is 85.9 per 100,000 for people aged 
65-69 years and 135 per 100,000 for those aged over 
80 years (38); similar status epilepticus appears to 
occur more frequently with significantly greater 
morbidity and mortality in this age group (39). There 
are focal seizures, automatisms without 
generalisation or with secondary generalisation, the 
postictal phase is prolonged with confusion and 
memory problems corresponding with focal changes 
on electroencephalograph (EEG) and neuroimaging 
epileptogenic lesion (40). Epilepsy are more common 
encountered with stroke - the risk of epilepsy 
increases up to 20-fold in the first year after a stroke, 
hypertensive encephalopathy, cerebral vasculitis, 
tumours (gliomas, meningiomas and metastases), 
trauma, dementia, Alzheimer's disease - are up to 10 
times more likely to develop epilepsy than those 
without the condition (38). To older patients there 
are: side-effects, toxicity, increased susceptibility to 
anti-epileptic drug, a mortality rate 2-3 times higher 
than the general population, a very variable 
prognosis depending on the epilepsy syndrome, the 
frequency of seizures, the response to treatment - an 
inadequate seizure control raise the suspicion of 
poor adherence or progressive neurodegenerative 
disease; social difficulties, multidisciplinary service 
requirements in the community (41).  
 
-cerebral tumours:  
meningiomas: are 12.8/100,000 incidence to those of 
≥ 65 years of age, increasing with age (42)  
In the elderly, meningiomas are diagnosed small, 
slow growing, asymptomatic extraaxial tumours 
without brain edema, even calcified, occurring more 
frequently in women than men (43). For such 
tumours therapeutic attitude are conservative 
clinical observation and radiologic follow-up (44-46). 
For clinically symptomatic and fast growing 
meningioma, especially atypical or malignant, to 
elderly patients with limited physiological capacities 
and comorbidities, surgery after a careful 
consideration should be the mainstay of treatment 
for local tumour control (47-52), to realise genetic 
and histological diagnosis (it's possible to the same 
patient to see meningiomatosis with different 
genetic and histologic behaviour: benign and 
malignant meningiomas), but also stereotactic 
radiotherapy (SRT), Gamma knife, Linac-based 
stereotactic radiosurgery effective in terms of 
tumour control and survival, safe with regard to 
toxicity - the overall rates of complications ranged 
from 2.7% to 29.8%, and the overall incidence of 
complications 20% (range, 3–61%)(53-59).  
 
Metastasis are increasing to the majority of cancer 
patients over the age of 65, not only cerebral or 
intradural spinal metastasis, but more frequent 
bone metastasis, involving the spine in approx. 50% 
(60). Elderly survivors of breast cancer, lung cancer, 
and melanoma face risk of brain metastasis later in 
life; rates of synchronous brain metastases incidence 
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proportions in lung, breast, and melanoma cancers 
were 9.6%, 0.3%, and 1.1%, respectively; such 
tumours may require extra surveillance in the years 
following initial cancer treatment. Non-small cell lung 
cancer made up the majority of lung cancer SBM IP, 
at 13.4%, and small-cell lung cancer made up the 
majority of lung cancer - lifetime brain metastases at 
23.1%. The most frequent spinal metastases (60%) 
are from breast, lung, or prostate cancer (61). The 
chance that an elderly patient (60–79 years old) is 
affected by bony metastases is four times higher in 
men and three times higher in women than a 
middle-aged patient (40–59 years old). Pain, neural 
compression with motor deficits, pathological 
fracture, and instability are the most common 
surgery indication. For cervical area: the occipito-
cervical junction can generally be treated by 
posterior resection and stabilization, in the middle 
and lower cervical spine the anterior approach with 
anterior decompression and anterior column 
reconstruction; in the thoraco-lumbar spine a 
posterior decompression and postero-lateral 
vertebral body resection through a posterior 
approach only, with a concomitant reconstruction 
and stabilization. There are also for paleative cases 
different treatment modalities—irradiation, 
chemotherapy, steroids, biphosphonates, morphine 
pump. Since prospective randomized studies 
comparing different treatment modalities for spinal 
metastases including surgery are not available and 
are ethically difficult to achieve, each case remains 
an interdisciplinary, shared decision-making process 
for what is considered best for a patient or elderly 
patient. However, whenever surgery is an option, it 
should be planned before irradiation since surgery 
after irradiation has a significant higher complication 
rate.  
Glioblastoma multiforme are at old age a high 
incidence, also most significant associated with poor 
prognosis, even after the introduction of 
temozolomide (TMZ) in 2006, without any clear 
borderline (62). After published statistics from the 
Japan Brain Tumour Registry from 2001 to 2004 (63), 
patients aged > 65 years and > 75 years accounting 
for 42% and 11.4%, respectively; the most frequent 
age group of patients was 65–69 years, which 
accounted for 17% of the cases, median overall 
survival was 15 months. GBMs are subdivided 
according to their molecular phenotype see WHO 
classification of central nervous system (CNS) 
tumour 2016 (64), namely, CpG island methylator 
phenotype (G-CIMP) and isocitrate dehydrogenase 
(IDH) mutation: IDH wild type and IDH mutant - 
absence of IDH mutation, is the most predominant 
GBM in the elderly. Also MGMT promoter 
methylation is independent of age, with 47% in the 
elderly, epidermal growth factor receptor - 
EGFR, p53, CDKN2A, PTEN were not prognostic 
factors (65), vascular endothelial growth factor 
(VEGF) was higher in GBM in the elderly than in 
young patients, also the prognostic value of 
telomerase reverse transcriptase (TERT) promoter 
mutation in GBM has been debated (66). Although 
age is a poor prognostic factor, old age alone is 
suggested to have no association with poor 
prognosis, an aggressive treatment should not be 
withheld because of old age (67). Multimodal 
treatment in elderly patients with GBM aged > 65 
years should include:  
 
-surgical resection: achieving maximal tumour 
cytoreduction within the safety margin, brain 
decompression, histopathological and genetic 
diagnosis especially for IDH mutation 
and MGMT methylation status. Such aggressive 
attitude may prolonge survival by 2.8 times than 
biopsy (median OS: 171 days after the craniotomy 
versus 85 days after the biopsy), also for aged 
patients ≥75 years may extend survival by 2 months, 
delayed tumour progression and improved 
functional prognosis (68-76). 
 
-radiotherapy - hypofractionated radiotherapy 
(Hypo-RT 40 Gy/15 Fr) alone can be considered if the 
tumour has an unmethylated MGMT promoter (77-
80) 
 
-with concurrent and adjuvant TMZ - in elderly 
patients with MGMT methylated tumours 
monotherapy with TMZ can expect prolonged 
survival (78-82); clinical benefits of bevacizumab use 
in remain unclear (83)(84), also lack of evidence 
regarding the efficacy of carmustine wafer (85)(86).  
another cerebral tumor: schwanoma, pituitary 
adenoma (87) 
 
-spinal pathology means for old patients a wide range 
of neurosurgical procedures to solve: 
spinal degenerative myeloradiculopathy, mielopathy 
with cervical canal stenosis, lumbar spinal stenosis 
(it's important to clarify that surgery will not give 
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another spine, also surgery is better to be done in a 
only surgical procedure); spinal tumours: extra/intra 
dural, intramedullary and more frequent vertebral 
metastasis in lung, brest or prostate cancers; spinal 
instability and osteoporotic vertebral changes. 
  
-chronic geriatric pain defined as “an unpleasant 
sensory and emotional experience associated with 
actual or potential tissue damage", is a longstanding 
pain that persists beyond the usual recovery period 
or occurs along with a chronic health condition, for 
greater than 3 months is a more frequent 
neuropathic, persistent, recurrent, underreported; 
much more difficult to treat especially for those with 
long-lasting pain compared to young people, 
justified by pain corticalisation (88). Such condition is 
impairing activities of daily living, ambulation, quality 
of life; more difficult to be understood especially to 
those patients with cognitive or language 
impairments; also may generate polypharmacy with 
concomitant medication, but also responsive for 
poor health, accidents, gait abnormalities, cognitive 
decline, denial, depression, psychosocial concerns, 
with direct and indirect estimated treatments costs 
close to $50 billion a year (89). There are several 
types of chronic pain, complex, multifactorial in older 
population, very debilitating and painful: trigeminal 
neuralgia, atypical facial pain, occipital neuralgia, 
postherpetic neuralgia, headache, stroke and 
phantom limb pain, failed spinal surgery, referred or 
pain related to cancer; also pain perception is more 
difficult to be treated. For such patients a 
multidisciplinary approach needs to be conceived: 
pharmacotherapy, psychological support, 
psychological support, also interventional 
procedures. A wide range of procedures (88) should 
be wisely proposed taking into account life 
expectancy, comorbidities, the patient's desire 
focusing on neuromodular rather than lesional 
techniques, also risks for each procedure: 
microvascular decompression, chemical neurolysis, 
radiofrequency and glycerol rhizotomy, stereotactic 
radiation, deep brain & spinal cord stimulation, 
motor cortex stimulation and neuraxial drug 
delivery. 
 
 -tremor (Parkinson's syndrome & disease and 
dystonic movements) treated especially by 
medication, DBS, motor cortex stimulation (90). 
 -neuro-infections especially to immunocompromise 
patients: diabetes, TB, HIV, etc. 
-multiple sclerosis 
-dementia 
 
CONCLUSIONS 
This study is a plea argue that in elderly patients, 
which is likely to continue to grow (6), risk factors 
should be adequately managed even in emergency 
(3), with correct preoperative evaluation, appropriate 
perioperative care (8), titrated anesthetic 
management, efficient surgical skills. Planned 
postoperative management may improve 
neurological status (30)(91), outcomes, reduce 
mortality rates, reduce length of intensive care stay, 
improved resource utilisation, fiscal benefits (7)(9). 
Further studies in the elderly are mandatory to be 
performed to improve clinical decisions on risk 
benefit ratios pending on new technologies.  
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